(1S,2S)-2-(乙酰氧基甲基)环丙烷羧酸 | 223800-41-7

• 分子结构分类: 有机化合物 - 有机酸及其衍生物 - 羧酸及其衍生物
• 中文名称: (1S,2S)-2-(乙酰氧基甲基)环丙烷羧酸
• 中文别名: 3-(6-{[4-(三氟甲氧基)苯基]氨基}嘧啶-4-基)苯酰胺
• 英文名称: (1S,2S)-2-Acetoxymethyl-cyclopropanecarboxylic acid
• 英文别名: (1S,2S)-2-[(Acetyloxy)methyl]cyclopropane-1-carboxylic acid；(1S,2S)-2-(acetyloxymethyl)cyclopropane-1-carboxylic acid
• CAS: 223800-41-7
• 化学式: C₇H₁₀O₄
• 分子量: 158.154
• InChiKey: MORWYGLVZPSWQJ-RITPCOANSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  0
• 重原子数：
  11
• 可旋转键数：
  4
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.71
• 拓扑面积：
  63.6
• 氢给体数：
  1
• 氢受体数：
  4

反应信息

• 作为反应物：
  描述：

  (1S,2S)-2-(乙酰氧基甲基)环丙烷羧酸 在 4-二甲氨基吡啶 、 ruthenium trichloride 、 sodium periodate 、 sodium methylate 、 N,N'-二环己基碳二亚胺 作用下， 以 甲醇 、 四氯化碳 、 二氯甲烷 、 水 、 乙腈 为溶剂， 生成 (1S,2S)-2-[(S)-3-Methyl-1-(3-methyl-butylcarbamoyl)-butylcarbamoyl]-cyclopropanecarboxylic acid
  参考文献：
  名称：

  Stereoselective synthesis of novel cyclopropyl analogues of known cysteine protease inhibitors

  摘要：

  Efficient synthesis of two novel analogues of some known protease inhibitors, via the isosteric replacement of oxirane/aziridine moiety of the parent compounds by cyclopropane ring, is described.

  DOI：

  10.1016/s0960-894x(99)00029-3
• 作为产物：
  描述：

  trans-(2-phenylcyclopropyl)methyl acetate 在 ruthenium trichloride 、 sodium periodate 作用下， 以 四氯化碳 、 水 、 乙腈 为溶剂， 以85%的产率得到(1S,2S)-2-(乙酰氧基甲基)环丙烷羧酸
  参考文献：
  名称：

  Stereoselective synthesis of novel cyclopropyl analogues of known cysteine protease inhibitors

  摘要：

  Efficient synthesis of two novel analogues of some known protease inhibitors, via the isosteric replacement of oxirane/aziridine moiety of the parent compounds by cyclopropane ring, is described.

  DOI：

  10.1016/s0960-894x(99)00029-3

文献信息

• Naphthyridines as inhibitors of HPK1
  申请人：Genentech, Inc.

  公开号：US10407424B2

  公开（公告）日：2019-09-10

  Naphthyridine compounds and their use as inhibitors of HPK1 are described. The compounds are useful in treating HPK1-dependent disorders and enhancing an immune response. Also described are methods of inhibiting HPK1, methods of treating HPK1-dependent disorders, methods for enhancing an immune response, and methods for preparing the naphthyridine compounds.

  介绍了萘啶类化合物及其作为 HPK1 抑制剂的用途。这些化合物可用于治疗 HPK1 依赖性疾病和增强免疫反应。还描述了抑制 HPK1 的方法、治疗 HPK1 依赖性疾病的方法、增强免疫反应的方法以及制备萘啶化合物的方法。
• ISOQUINOLINES AS INHIBITORS OF HPK1
  申请人：Genentech, Inc.

  公开号：US20210163417A1

  公开（公告）日：2021-06-03

  Isoquinoline compounds and their use as inhibitors of HPK1 (hematopoietic kinase 1) are described. The compounds are useful in treating HPK1-dependent disorders and enhancing an immune response. Also described are methods of inhibiting HPK1, methods of treating HPK1-dependent disorders, methods for enhancing an immune response, and methods for preparing the isoquinoline compounds.
• Stereoselective synthesis of novel cyclopropyl analogues of known cysteine protease inhibitors
  作者：Jalluri S. Ravi Kumar、Subho Roy、Apurba Datta

  DOI：10.1016/s0960-894x(99)00029-3

  日期：1999.2

  Efficient synthesis of two novel analogues of some known protease inhibitors, via the isosteric replacement of oxirane/aziridine moiety of the parent compounds by cyclopropane ring, is described.